Andrew Mitchell - Ryman Healthcare Development Manager
RYHTY Stock | USD 12.86 0.19 1.46% |
Executive
Mr. Andrew Mitchell is Development Manager of the company. He joined Ryman after working as a Regional Development Manager for Sunrise Senior Living in the UK. He holds a Bachelor of Commerce in Valuation and Property Management.
Phone | 64 3 366 4069 |
Web | https://www.rymanhealthcare.co.nz |
Ryman Healthcare Management Efficiency
Ryman Healthcare's management efficiency ratios could be used to measure how well Ryman Healthcare manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Showing other executives | EXECUTIVE Age | ||
Dylan Black | Enhabit | 54 | |
Nathan Vaughn | ModivCare | N/A | |
Matthew Callister | Concord Medical Services | 50 | |
Lynette CPA | Pennant Group | 47 | |
Isa Diaz | Acadia Healthcare | N/A | |
Heather CPA | Acadia Healthcare | 52 | |
Rauly Gutierrez | InnovAge Holding Corp | N/A | |
Anderson Sr | National HealthCare | 62 | |
Gretchen Hommrich | Acadia Healthcare | N/A | |
MS DO | Encompass Health Corp | 64 | |
Cheryl Levy | Encompass Health Corp | 58 | |
FACP MD | InnovAge Holding Corp | 57 | |
Laura Groschen | Acadia Healthcare | N/A | |
Langham MBA | Enhabit | 47 | |
Bill Priest | Acadia Healthcare | N/A | |
Matt Huray | InnovAge Holding Corp | N/A | |
RN BSN | Enhabit | 66 | |
Nicole DAmato | InnovAge Holding Corp | 45 | |
Kim Sullivan | Encompass Health Corp | N/A | |
Jing Zhang | Concord Medical Services | 49 | |
Mark Palmenter | Acadia Healthcare | N/A |
Management Performance
Return On Equity | 0.18 | |||
Return On Asset | -7.0E-4 |
Ryman Healthcare Leadership Team
Elected by the shareholders, the Ryman Healthcare's board of directors comprises two types of representatives: Ryman Healthcare inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Ryman. The board's role is to monitor Ryman Healthcare's management team and ensure that shareholders' interests are well served. Ryman Healthcare's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Ryman Healthcare's outside directors are responsible for providing unbiased perspectives on the board's policies.
Claire Higgins, Non-Executive Independent Director | ||
Anthony Leighs, Independent Director | ||
Cameron Holland, Chief Australia | ||
Richard Umbers, Group Exec | ||
Gordon MacLeod, CFO, Deputy Chief Executive and Company Secretary | ||
Kevin Hickman, Co-Founder, Director and Member of Remuneration and Nominations Committee | ||
Taylor Allison, Design Manager | ||
Michelle Perkins, IR Contact Officer | ||
Simon Challies, CEO, Managing Director, Executive Director | ||
Tom Brownrigg, Construction Manager | ||
Jo Appleyard, Independent Non-Executive Director | ||
Jenn Poskitt, Marketing Manager | ||
Philip Mealings, Property and Purchasing Manager | ||
George Savvides, Independent Director | ||
Douglas McKay, Independent Director | ||
Cheyne Chalmers, Chief Zealand | ||
Debbie McClure, Group Sales Manager | ||
Warren Bell, Independent Non-Executive Director | ||
David Bennett, Group Officer | ||
Deborah Marris, G Sec | ||
Marsha Cadman, Chief Officer | ||
Rick Davies, Chief Officer | ||
Andrew Mitchell, Development Manager | ||
David Kerr, Independent Non-Executive Chairman of the Board | ||
Geoffrey Cumming, Director | ||
MaryAnne Stone, Chief Officer | ||
David King, Corporate Affairs Manager | ||
Chris BE, Chief Officer | ||
Barbara ReynenRose, Operations & Clinical Services Manager | ||
Nicole Forster, Group Shared Services Manager |
Ryman Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Ryman Healthcare a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.18 | |||
Return On Asset | -7.0E-4 | |||
Profit Margin | 1.13 % | |||
Operating Margin | (0.02) % | |||
Current Valuation | 3.91 B | |||
Shares Outstanding | 100 M | |||
Price To Earning | 10.13 X | |||
Price To Book | 0.85 X | |||
Price To Sales | 3.74 X | |||
Revenue | 503.76 M |
Currently Active Assets on Macroaxis
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Ryman Healthcare Ltd. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Complementary Tools for Ryman Pink Sheet analysis
When running Ryman Healthcare's price analysis, check to measure Ryman Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ryman Healthcare is operating at the current time. Most of Ryman Healthcare's value examination focuses on studying past and present price action to predict the probability of Ryman Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ryman Healthcare's price. Additionally, you may evaluate how the addition of Ryman Healthcare to your portfolios can decrease your overall portfolio volatility.
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |